695. Deputy John Lahart asked the Minister for Health if the cost of the gene therapy drug, Luxturna, that treats inherited retinal diseases such as retinitis pigmentosa, RP, and Leber congenital amaurosis, LCA, will be included as part of the additional €50 million in funding for new medicines allocated as part of Budget 2021; if he will consider funding when making a recommendation to the HSE drugs group; and if he will make a statement on the matter. [3717/21]

Summary

695. Deputy John Lahart asked the Minister for Health if the cost of the gene therapy drug, Luxturna, that treats inherited retinal diseases such as retinitis pigmentosa, RP, and Leber congenital amaurosis, LCA, will be included as part of the additional €50 million in funding for new medicines allocated as part of Budget 2021; if he will consider funding when making a recommendation to the HSE drugs group; and if he will make a statement on the matter. [3717/21]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 27 January 2021

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.